These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 1330161

  • 21. The monocyte-derived neutrophil activating peptide (NAP/interleukin 8) stimulates human neutrophil arachidonate-5-lipoxygenase, but not the release of cellular arachidonate.
    Schröder JM.
    J Exp Med; 1989 Sep 01; 170(3):847-63. PubMed ID: 2549166
    [Abstract] [Full Text] [Related]

  • 22. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generation.
    Grimminger F, Hattar K, Papavassilis C, Temmesfeld B, Csernok E, Gross WL, Seeger W, Sibelius U.
    J Exp Med; 1996 Oct 01; 184(4):1567-72. PubMed ID: 8879231
    [Abstract] [Full Text] [Related]

  • 23. Kinetics of 5-lipoxygenase activation, arachidonic acid release, and leukotriene synthesis in human neutrophils: effects of granulocyte-macrophage colony-stimulating factor.
    Krump E, Borgeat P.
    Biochim Biophys Acta; 1994 Jul 14; 1213(2):135-9. PubMed ID: 8025123
    [Abstract] [Full Text] [Related]

  • 24. Differential effects of lipoxygenase products on FMLP and LTB4 evoked neutrophil aggregation.
    Beckman JK, Gay JC, Brash AR, Lukens JN, Oates JA.
    Lipids; 1985 Jun 14; 20(6):357-60. PubMed ID: 2991693
    [Abstract] [Full Text] [Related]

  • 25. Enhancement of platelet-activating factor-induced leukotriene synthesis in neutrophils by granulocyte-macrophage colony-stimulating factor (GM-CSF): studies on the mechanism of action of GM-CSF.
    McColl SR, Krump E, McDonald PP, Braquet M, Naccache PH, Borgeat P.
    J Lipid Mediat; 1990 Jun 14; 2 Suppl():S119-27. PubMed ID: 1966811
    [Abstract] [Full Text] [Related]

  • 26. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
    Harizi H, Juzan M, Moreau JF, Gualde N.
    J Immunol; 2003 Jan 01; 170(1):139-46. PubMed ID: 12496393
    [Abstract] [Full Text] [Related]

  • 27. Time-dependent utilization of platelet arachidonic acid by the neutrophil in formation of 5-lipoxygenase products in platelet-neutrophil co-incubations.
    Antoine C, Murphy RC, Henson PM, Maclouf J.
    Biochim Biophys Acta; 1992 Oct 30; 1128(2-3):139-46. PubMed ID: 1329972
    [Abstract] [Full Text] [Related]

  • 28. Stereospecificity of leukotriene B4 and structure-function relationships for chemotaxis of human neutrophils.
    Dahinden CA, Clancy RM, Hugli TE.
    J Immunol; 1984 Sep 30; 133(3):1477-82. PubMed ID: 6086758
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Intracellular retention of the 5-lipoxygenase pathway product, leukotriene B4, by human neutrophils activated with unopsonized zymosan.
    Williams JD, Lee TH, Lewis RA, Austen F.
    J Immunol; 1985 Apr 30; 134(4):2624-30. PubMed ID: 2982947
    [Abstract] [Full Text] [Related]

  • 31. Insoluble immune complex-stimulated neutrophil leukotriene B4 production is dependent on Fc gamma RII and Fc gamma RIII and independent of pertussis toxin-sensitive signal transduction pathways.
    Crockett-Torabi E, Smith CW, Kateley JR, Patterson R, Tsai P, Fantone JC.
    Am J Pathol; 1992 Mar 30; 140(3):613-20. PubMed ID: 1312307
    [Abstract] [Full Text] [Related]

  • 32. Quantitation of 5-lipoxygenase products by electrospray mass spectrometry: effect of ethanol on zymosan-stimulated production of 5-lipoxygenase products by human neutrophils.
    Wheelan P, Murphy RC.
    Anal Biochem; 1997 Jan 01; 244(1):110-5. PubMed ID: 9025916
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Studies of the inhibitory activity of MK-0591 (3-[1-(4-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-yl-methoxy)-indol- 2-yl]-2,2-dimethyl propanoic acid) on arachidonic acid metabolism in human phagocytes.
    Ménard L, Laviolette M, Borgeat P.
    Can J Physiol Pharmacol; 1992 Jun 01; 70(6):808-13. PubMed ID: 1423024
    [Abstract] [Full Text] [Related]

  • 35. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors.
    Feltner DE, Smith RH, Marasco WA.
    J Immunol; 1986 Sep 15; 137(6):1961-70. PubMed ID: 3018082
    [Abstract] [Full Text] [Related]

  • 36. 6-trans-leukotriene B4 is a neutrophil chemotaxin in the guinea pig dermis.
    Fretland DJ, Widomski DL, Anglin CP, Walsh RE, Levin S, Gaginella TS.
    J Leukoc Biol; 1991 Mar 15; 49(3):283-8. PubMed ID: 1847716
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Granulocyte-macrophage colony-stimulating factor increases the synthesis of leukotriene B4 by human neutrophils in response to platelet-activating factor. Enhancement of both arachidonic acid availability and 5-lipoxygenase activation.
    McColl SR, Krump E, Naccache PH, Poubelle PE, Braquet P, Braquet M, Borgeat P.
    J Immunol; 1991 Feb 15; 146(4):1204-11. PubMed ID: 1846895
    [Abstract] [Full Text] [Related]

  • 40. Leukotriene B4 stimulates the release of arachidonate in human neutrophils via the action of cytosolic phospholipase A2.
    Burke JR, Davern LB, Gregor KR, Tramposch KM.
    Biochim Biophys Acta; 1997 Oct 30; 1359(1):80-8. PubMed ID: 9398088
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.